Similar articles

• [Comments on recent guidelines for the treatment of tuberculosis by the American Thoracic Society, the Centers for Disease Control and Prevention, and the Infectious Diseases Society of America].

  Caminero Luna JA; American Thoracic Society, the Centers for Disease Control and Prevention; Infectious Diseases Society of America. Caminero Luna JA, et al. Arch Bronconeumol. 2003 Sep;39(9):379-81. doi: 10.1016/s0300-2896(03)75411-8. Arch Bronconeumol. 2003. PMID: 12975067 Spanish. No abstract available.
• [Treatment of drug resistant tuberculosis].

  Perel'man MI, Sokolova GB, Borisov SE, Kunichan AD, Lazareva IaV, Mozhokina GN, Elistratova NA, Tsybanev AA. Perel'man MI, et al. Antibiot Khimioter. 2003;48(8):28-36. Antibiot Khimioter. 2003. PMID: 14722939 Review. Russian. No abstract available.
• Further acquisition of drug-resistance in multidrug-resistant tuberculosis during chemotherapy.

  Toyota E, Sekiguchi J, Shimizu H, Fujino T, Otsuka Y, Yoshikura H, Kuratsuji T, Kirikae T, Kudo K. Toyota E, et al. Jpn J Infect Dis. 2004 Dec;57(6):292-4. Jpn J Infect Dis. 2004. PMID: 15623961 No abstract available.
• The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in Vietnam.

  Buu TN, Huyen MN, van Soolingen D, Lan NT, Quy HT, Tiemersma EW, Borgdorff MW, Cobelens FG. Buu TN, et al. Clin Infect Dis. 2010 Oct 15;51(8):879-86. doi: 10.1086/656410. Clin Infect Dis. 2010. PMID: 20836697
• Drug resistance in tuberculosis.

  Parsons LM, Driscoll JR, Taber HW, Salfinger M. Parsons LM, et al. Infect Dis Clin North Am. 1997 Dec;11(4):905-28. doi: 10.1016/s0891-5520(05)70397-4. Infect Dis Clin North Am. 1997. PMID: 9421707 Review.